Probiotics can help heal ravaged coral reefs
Probiotics are everywhere, claiming to help us poop, restore gut health, and more. They can also be used to help threatened coral reefs. A bacterial probiotic has helped slow the spread of stony coral tissue loss disease (SCTLD) in wild corals in Florida that were already infected with the disease. The findings are detailed in a study published June 5 in the journal Frontiers in Marine Science and show that applying this new probiotic treatment across coral colines helped prevent further tissue loss.
SCTLD first emerged in Florida in 2014. In the 11 years since, it has rapidly spread throughout the Caribbean. This mysterious ailment has been confirmed in at least 20 other countries and territories.
Other coral pathogens typically target specific species. SCTLD infects more than 30 different species of stony corals, including pillar corals and brain corals. The disease causes the soft tissue in the corals to slough off, leaving behind white patches of exposed skeleton. The disease can devastate an entire coral colony in only a few weeks to months.
The exact cause of SCTLD is still unknown, but it appears to be linked to some kind of harmful bacteria. Currently, the most common treatment for SCTLD is using a paste that contains the antibiotic amoxicillin on diseased corals. However, antibiotics are not a silver bullet. This amoxicillin balm can temporarily halt SCTLD's spread, but it needs to be frequently reapplied to the lesions on the corals. This takes time and resources, while increasing the likelihood that the microbes causing SCTLD might develop resistance to amoxicillin and related antibiotics.
'Antibiotics do not stop future outbreaks,' Valerie Paul, a study co-author and the head scientist at the Smithsonian Marine Station at Fort Pierce, Florida, said in a statement. 'The disease can quickly come back, even on the same coral colonies that have been treated.'
Paul and her colleagues have spent over six years investigating whether beneficial microorganisms (aka probiotics) could be a longer lasting alternative to combat this pathogen.
Just like humans, corals are host to communities known as microbiomes that are bustling with all different types of bacteria. Some of these miniscule organisms produce antioxidants and vitamins that can help keep their coral hosts healthy.
[ Related: Caribbean coral is getting sick and dying. A probiotic could help. ]
First, the team looked at the microbiomes of corals that are impervious to SCTLD to try and harvest probiotics from these disease-resistant species. In theory, these could be used to strengthen the microbiomes of susceptible corals.
They tested over 200 strains of bacteria from disease-resistant corals and published a study in 2023 about the probiotic Pseudoalteromonas sp. McH1-7 (or McH1-7 for short). Taken from the great star coral (Montastraea cavernosa), this probiotic produces several antibacterial compounds. Having such a stacked antibacterial toolbox made McH1-7 an ideal candidate to combat a pathogen like SCTLD.
They initially tested McH1-7 on live pieces of M. cavernosa and found that the probiotic reliably prevented the spread of SCTLD in the lab. After these successful lab tests, the wild ocean called next.
The team conducted several field tests on a shallow reef near Fort Lauderdale, focusing on 40 M. cavernosa colonies that showed signs of SCTLD. Some of the corals in these colonies received a paste containing the probiotic McH1-7 that was applied directly to the disease lesions. They treated the other corals with a solution of seawater containing McH1-7 and covered them using weighted plastic bags. The probiotics were administered inside the bag in order to cover the entire coral colony.
'This created a little mini-aquarium that kept the probiotics around each coral colony,' Paul said.
For two and a half years, they monitored the colonies, taking multiple rounds of tissue and mucus samples to see how the corals' microbiomes were changing over time. They found that the McH1-7 probiotic successfully slowed the spread of SCTLD when it was delivered to the entire colony using the bag and solution method. According to the samples, the probiotic was effective without dominating the corals' natural microbes.
While using this probiotic appears to be an effective treatment for SCTLD among the reefs of northern Florida, additional work is needed to see how it could work in other regions. Similar tests on reefs in the Florida Keys have been conducted, with mixed preliminary results, likely due to regional differences in SCTLD.
The team believes that probiotics still could become a crucial tool for combatting SCTLD across the Caribbean, especially as scientists fine tune how to administer them. Importantly, these beneficial bacteria support what corals already do naturally.
'Corals are naturally rich with bacteria and it's not surprising that the bacterial composition is important for their health,' Paul said. 'We're trying to figure out which bacteria can make these vibrant microbiomes even stronger.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Probiotics can help heal ravaged coral reefs
Probiotics are everywhere, claiming to help us poop, restore gut health, and more. They can also be used to help threatened coral reefs. A bacterial probiotic has helped slow the spread of stony coral tissue loss disease (SCTLD) in wild corals in Florida that were already infected with the disease. The findings are detailed in a study published June 5 in the journal Frontiers in Marine Science and show that applying this new probiotic treatment across coral colines helped prevent further tissue loss. SCTLD first emerged in Florida in 2014. In the 11 years since, it has rapidly spread throughout the Caribbean. This mysterious ailment has been confirmed in at least 20 other countries and territories. Other coral pathogens typically target specific species. SCTLD infects more than 30 different species of stony corals, including pillar corals and brain corals. The disease causes the soft tissue in the corals to slough off, leaving behind white patches of exposed skeleton. The disease can devastate an entire coral colony in only a few weeks to months. The exact cause of SCTLD is still unknown, but it appears to be linked to some kind of harmful bacteria. Currently, the most common treatment for SCTLD is using a paste that contains the antibiotic amoxicillin on diseased corals. However, antibiotics are not a silver bullet. This amoxicillin balm can temporarily halt SCTLD's spread, but it needs to be frequently reapplied to the lesions on the corals. This takes time and resources, while increasing the likelihood that the microbes causing SCTLD might develop resistance to amoxicillin and related antibiotics. 'Antibiotics do not stop future outbreaks,' Valerie Paul, a study co-author and the head scientist at the Smithsonian Marine Station at Fort Pierce, Florida, said in a statement. 'The disease can quickly come back, even on the same coral colonies that have been treated.' Paul and her colleagues have spent over six years investigating whether beneficial microorganisms (aka probiotics) could be a longer lasting alternative to combat this pathogen. Just like humans, corals are host to communities known as microbiomes that are bustling with all different types of bacteria. Some of these miniscule organisms produce antioxidants and vitamins that can help keep their coral hosts healthy. [ Related: Caribbean coral is getting sick and dying. A probiotic could help. ] First, the team looked at the microbiomes of corals that are impervious to SCTLD to try and harvest probiotics from these disease-resistant species. In theory, these could be used to strengthen the microbiomes of susceptible corals. They tested over 200 strains of bacteria from disease-resistant corals and published a study in 2023 about the probiotic Pseudoalteromonas sp. McH1-7 (or McH1-7 for short). Taken from the great star coral (Montastraea cavernosa), this probiotic produces several antibacterial compounds. Having such a stacked antibacterial toolbox made McH1-7 an ideal candidate to combat a pathogen like SCTLD. They initially tested McH1-7 on live pieces of M. cavernosa and found that the probiotic reliably prevented the spread of SCTLD in the lab. After these successful lab tests, the wild ocean called next. The team conducted several field tests on a shallow reef near Fort Lauderdale, focusing on 40 M. cavernosa colonies that showed signs of SCTLD. Some of the corals in these colonies received a paste containing the probiotic McH1-7 that was applied directly to the disease lesions. They treated the other corals with a solution of seawater containing McH1-7 and covered them using weighted plastic bags. The probiotics were administered inside the bag in order to cover the entire coral colony. 'This created a little mini-aquarium that kept the probiotics around each coral colony,' Paul said. For two and a half years, they monitored the colonies, taking multiple rounds of tissue and mucus samples to see how the corals' microbiomes were changing over time. They found that the McH1-7 probiotic successfully slowed the spread of SCTLD when it was delivered to the entire colony using the bag and solution method. According to the samples, the probiotic was effective without dominating the corals' natural microbes. While using this probiotic appears to be an effective treatment for SCTLD among the reefs of northern Florida, additional work is needed to see how it could work in other regions. Similar tests on reefs in the Florida Keys have been conducted, with mixed preliminary results, likely due to regional differences in SCTLD. The team believes that probiotics still could become a crucial tool for combatting SCTLD across the Caribbean, especially as scientists fine tune how to administer them. Importantly, these beneficial bacteria support what corals already do naturally. 'Corals are naturally rich with bacteria and it's not surprising that the bacterial composition is important for their health,' Paul said. 'We're trying to figure out which bacteria can make these vibrant microbiomes even stronger.'
Yahoo
2 days ago
- Yahoo
Will norovirus surge early again this year? Here's what scientists say
Will the upcoming norovirus season be just as early and active as the past year? While the answer may be anyone's guess right now, federal health officials recently warned that the dominant strain of the contagious virus — the leading cause of vomiting, diarrhea, and foodborne illness in the U.S. — has changed between the 2022-2023 and 2024-2025 seasons. 'GII.17 has caused 75 percent of all norovirus outbreaks during the 2024–25 season so far, thereby replacing GII.4 as the predominant norovirus outbreak strain in the United States,' Centers for Disease Control researchers wrote in an article published this month by the agency's Emerging Infectious Diseases journal. This past season also started at the earlier date of October, as opposed to December. GII.17 also drove a record wave of outbreaks. But, what all of this might mean going forward needs further research. 'Additional sequence analysis of complete GII.17 genomes and identification of cross-protective neutralizing antibodies of GII.17 compared with GII.4 viruses could help clarify whether GII.17 viruses will persist. Continued surveillance is needed to determine if this genotype remains the dominant genotype, as well as whether the norovirus season continues to start earlier than previous years,' they wrote. A spokesperson for the agency told CBS News that there are 'currently insufficient historic data to predict whether norovirus GII.17 will remain the dominant genotype and lead to an earlier onset of the norovirus season later this year.' They pointed to a surge of GII.17 strains in Asia and Europe in 2014 that was followed by no reports of a change to seasonality, and noted that there has been no clear evidence to prove that GII.17's emergence was the cause of a change to the norovirus season last year. Still, this past season reached the worst levels in a decade. There were 91 suspected or confirmed outbreaks during the first week of December, which Yale Medicine said exceeded the number of outbreaks during the same week in any year since 2012. The majority were the GII.7 strain. In years when there is a new strain of the virus, there can be 50 percent more norovirus illness. Cases continued to tick up months into this year. By May 7, there were 2,571 outbreaks. During the same time last year, there were only 1,358. 'The total number of outbreaks reported during the 2024 to 2025 seasonal year is above the range reported during the same period during the 2012 to 2020 and 2021 to 2024 seasonal years,' the CDC said. Cases have fallen markedly since January, and are now at low levels. While the outbreaks occur throughout the year, they are the most common from November to April as people head indoors and it's easier to spread norovirus through infected particles. Anyone who consumes raw shellfish is also at risk of contracting it. Infection can be deadly largely among adults aged 65 and up, but anyone can get sick. Children younger than 5 years old and people with weakened immune systems are more likely to develop severe infections. There are 900 deaths on average each year and between 19 and 21 million illnesses. There's no specific treatment for norovirus, but most people recover with a period of up to three days. 'The norovirus can spread so quickly, but also, as we already talked about, norovirus can be very — it's usually very fast. So yeah, if people are taking care of themselves, we leave them alone,' explained Dr. Joanna Bisgrove, a family physician at Rush University Medical Center. 'But if it keeps going, we're like, maybe this isn't norovirus, and we need to do other things.'
Yahoo
2 days ago
- Yahoo
Will norovirus surge early again this year? Here's what scientists say
Will the upcoming norovirus season be just as early and active as the past year? While the answer may be anyone's guess right now, federal health officials recently warned that the dominant strain of the contagious virus — the leading cause of vomiting, diarrhea, and foodborne illness in the U.S. — has changed between the 2022-2023 and 2024-2025 seasons. 'GII.17 has caused 75 percent of all norovirus outbreaks during the 2024–25 season so far, thereby replacing GII.4 as the predominant norovirus outbreak strain in the United States,' Centers for Disease Control researchers wrote in an article published this month by the agency's Emerging Infectious Diseases journal. This past season also started at the earlier date of October, as opposed to December. GII.17 also drove a record wave of outbreaks. But, what all of this might mean going forward needs further research. 'Additional sequence analysis of complete GII.17 genomes and identification of cross-protective neutralizing antibodies of GII.17 compared with GII.4 viruses could help clarify whether GII.17 viruses will persist. Continued surveillance is needed to determine if this genotype remains the dominant genotype, as well as whether the norovirus season continues to start earlier than previous years,' they wrote. A spokesperson for the agency told CBS News that there are 'currently insufficient historic data to predict whether norovirus GII.17 will remain the dominant genotype and lead to an earlier onset of the norovirus season later this year.' They pointed to a surge of GII.17 strains in Asia and Europe in 2014 that was followed by no reports of a change to seasonality, and noted that there has been no clear evidence to prove that GII.17's emergence was the cause of a change to the norovirus season last year. Still, this past season reached the worst levels in a decade. There were 91 suspected or confirmed outbreaks during the first week of December, which Yale Medicine said exceeded the number of outbreaks during the same week in any year since 2012. The majority were the GII.7 strain. In years when there is a new strain of the virus, there can be 50 percent more norovirus illness. Cases continued to tick up months into this year. By May 7, there were 2,571 outbreaks. During the same time last year, there were only 1,358. 'The total number of outbreaks reported during the 2024 to 2025 seasonal year is above the range reported during the same period during the 2012 to 2020 and 2021 to 2024 seasonal years,' the CDC said. Cases have fallen markedly since January, and are now at low levels. While the outbreaks occur throughout the year, they are the most common from November to April as people head indoors and it's easier to spread norovirus through infected particles. Anyone who consumes raw shellfish is also at risk of contracting it. Infection can be deadly largely among adults aged 65 and up, but anyone can get sick. Children younger than 5 years old and people with weakened immune systems are more likely to develop severe infections. There are 900 deaths on average each year and between 19 and 21 million illnesses. There's no specific treatment for norovirus, but most people recover with a period of up to three days. 'The norovirus can spread so quickly, but also, as we already talked about, norovirus can be very — it's usually very fast. So yeah, if people are taking care of themselves, we leave them alone,' explained Dr. Joanna Bisgrove, a family physician at Rush University Medical Center. 'But if it keeps going, we're like, maybe this isn't norovirus, and we need to do other things.'